BioCentury | Mar 19, 2021
Deals

March 18 Quick Takes: SPAC Revolution, Idera, Translate tumble; plus Anima-Takeda, Boston-GSK, Accelmed, Gain IPO and more

...medical devices, diagnostics, digital health and technology-enabled healthcare services.Gain raises $40M in IPODrug discovery company Gain Therapeutics Inc....
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...Response to COVID-19” ). Gain closes $10M B round Rare genetic and neurodegenerative diseases company Gain Therapeutics Inc....
...Histamine H4 receptor BioCentury Staff adriforant (ZPL389) risdiplam (RG7916, RO7034067) Ziarco Group Ltd. Novartis AG Royalty Pharma plc PTC Therapeutics Inc. CureVac N.V. Gain Therapeutics Inc. COVID-19...
BioCentury | Jun 20, 2019
Targets & Mechanisms

Moving beyond the active site: why allostery is newly in fashion

...SHP-2 (SHPTP2; PTPN11) - Src homology protein tyrosine phosphatase 2 Allison Johnson, Staff Writer Black Diamond Therapeutics Inc. Gain Therapeutics Inc. HotSpot...
BioCentury | Jul 17, 2018
Product R&D

Natural spots

...S6 kinase 70kDa polypeptide 1 Karen Tkach Tuzman, Associate Editor Nimbus Therapeutics LLC Relay Therapeutics Revolution Medicines Inc. HotSpot Therapeutics Inc. Gain Therapeutics Inc. Protein...
Items per page:
1 - 4 of 4
BioCentury | Mar 19, 2021
Deals

March 18 Quick Takes: SPAC Revolution, Idera, Translate tumble; plus Anima-Takeda, Boston-GSK, Accelmed, Gain IPO and more

...medical devices, diagnostics, digital health and technology-enabled healthcare services.Gain raises $40M in IPODrug discovery company Gain Therapeutics Inc....
BioCentury | Jul 22, 2020
Finance

July 21 Quick Takes: Royalty to reap risdiplam royalties; plus CureVac, Antengene, Citrine, Verona, Novartis, Amicus, Aslan, SAB, Gain

...Response to COVID-19” ). Gain closes $10M B round Rare genetic and neurodegenerative diseases company Gain Therapeutics Inc....
...Histamine H4 receptor BioCentury Staff adriforant (ZPL389) risdiplam (RG7916, RO7034067) Ziarco Group Ltd. Novartis AG Royalty Pharma plc PTC Therapeutics Inc. CureVac N.V. Gain Therapeutics Inc. COVID-19...
BioCentury | Jun 20, 2019
Targets & Mechanisms

Moving beyond the active site: why allostery is newly in fashion

...SHP-2 (SHPTP2; PTPN11) - Src homology protein tyrosine phosphatase 2 Allison Johnson, Staff Writer Black Diamond Therapeutics Inc. Gain Therapeutics Inc. HotSpot...
BioCentury | Jul 17, 2018
Product R&D

Natural spots

...S6 kinase 70kDa polypeptide 1 Karen Tkach Tuzman, Associate Editor Nimbus Therapeutics LLC Relay Therapeutics Revolution Medicines Inc. HotSpot Therapeutics Inc. Gain Therapeutics Inc. Protein...
Items per page:
1 - 4 of 4